Aster CMI Hospital Launches ‘PEARL’: Karnataka’s First Pediatric Emergency and Advanced Response Liver Care for children

IMT News Desk
IMT News Desk
· 2 min read
Aster CMI Hospital launches PEARL – Karnataka’s 1st Pediatric Emergency & Advanced Response Liver Care ICU for kids.

Aster CMI Hospital has announced the launch of PEARL (Pediatric Emergency and Advanced Response for Liver Care) – Karnataka’s first dedicated Pediatric Liver Intensive Care Unit (ICU). This specialized unit has been purpose-built to exclusively manage children with severe and life-threatening liver conditions.

Pediatric liver emergencies often escalate rapidly, leading to complications such as brain swelling, infections, organ failure, and metabolic disturbances. Equipped with advanced monitoring systems and supported by a multidisciplinary team of pediatric hepatologists, liver transplant surgeons, intensivists, anesthetists, infectious disease specialists, and specially trained liver ICU nurses, PEARL enables rapid response, precision care, and continuous monitoring during critical moments.


Prof. (Dr.) N. Karthik Nagesh, Program Director, Pediatric Centre’s of Excellence, Aster CMI Hospital, Karnataka, said, “With PEARL, we can initiate early, targeted interventions and provide continuous, liver-focused critical care tailored specifically for children. This approach significantly improves clinical outcomes and, in some cases, supports recovery without the need for liver transplantation”.

Dr Sonal Asthana, Program Director, Hepatobiliary Surgery and Multiorgan Transplantation, Aster CMI Hospital, Karnataka, said, “The Aster Integrated Liver Care Team is Karnataka’s largest liver care and transplant provider, treating more than 7000 patients with liver disease annually. It performs more than 100 liver transplantation procedures in Bangalore annually, of which a significant number are for Pediatric liver failure. The launch of a dedicated Pediatric liver ICU highlights our commitment to providing world-class interdisciplinary care for these very sick children”.


Dr. Prashanth N, CEO, Aster Hospitals, Karnataka
, added, “The launch of PEARL reflects our commitment to redefining pediatric critical care. By establishing a dedicated liver ICU backed by expert multidisciplinary teams, we are strengthening our ability to deliver timely, specialized, and comprehensive care for critically ill children, while setting new benchmarks in pediatric healthcare”.

With the launch of PEARL, Aster CMI Hospital is reshaping the pediatric healthcare landscape by introducing a dedicated, highly specialized liver care ecosystem combining clinical expertise, advanced technology, and compassionate care to improve outcomes for children across the region.

Read Next

India’s first focused health AI Conclave unites doctors and AI experts
Featured Article
July 10, 2026

India’s first focused health AI Conclave unites doctors and AI experts

• Global Healthcare Academy hosts HAI Conclave 2026, India’s first national platform dedicated to Healthcare and Artificial Intelligence • Landmark Bengaluru conference brings together healthcare leaders and AI experts to explore how Artificial Intelligence can make healthcare faster, safer and more accessible while keeping patients at the centre of every decision The inaugural edition of the HAI Conclave […]
Article by: IMT News Desk
Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026
News
July 10, 2026

Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026

Fischer Medical Ventures Limited (FMVL) has announced that its strategic partner, Nanyang Biologics, has achieved a major international milestone with its AI-powered molecular research platform, NYB.AI, being featured in the opening showcase at NVIDIA GTC Taiwan 2026, ahead of the keynote address by NVIDIA Founder and CEO Jensen Huang. The recognition places NYB.AI among a […]
Article by: IMT News Desk
Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs
News
July 10, 2026

Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs

Indian pharmaceutical companies are expected to report healthy revenue growth in the first quarter of FY27, but margins are likely to compress as sector profitability comes under pressure. In a recent preview note, Goldman Sachs said it anticipates around 185 basis points year-on-year margin decline for the sector in the June quarter, driven primarily by […]
Article by: IMT News Desk
Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue
News
July 10, 2026

Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue

Dr Reddy’s Laboratories has announced a delay in commercial supplies of its semaglutide product after certain batches were found to be out of specification due to an issue with the active pharmaceutical ingredient (API) used in the drug. The company said it has initiated an investigation into the root cause and is taking corrective measures […]
Article by: IMT News Desk